-
Also known as Elamipretide, a mitochondrial-targeting peptide evaluated for restoring cardiolipin integrity, reducing ROS, and improving ATP output in mitochondrial dysfunction. -
A lipotropic compound blend studied for supporting hepatic fat metabolism and methylation pathways. Common ingredients include MIC (methionine, inositol, choline) and B vitamins. -
Dual GIP and GLP-1 receptor agonist studied for glycemic control and weight loss. Demonstrates superior metabolic improvements in rodent and primate models. -
GLP-1 receptor agonist studied for appetite regulation, glucose control, and weight management. Evaluated in multiple metabolic and diabetic models. -
A growth hormone-releasing hormone analog used in research on pituitary stimulation and downstream GH/IGF-1 activity. -
Synthetic version of thymosin beta-4, evaluated for wound healing, inflammation modulation, and actin regulation across musculoskeletal tissues. -
GHRH analog studied for lipolytic activity, particularly targeting visceral fat. Originally developed for HIV-associated lipodystrophy. -
A melanocortin receptor agonist investigated for skin pigmentation modulation, sexual arousal, and appetite suppression in animal models. -
A neuropeptide associated with social bonding, trust, and reproductive behavior. Examined for CNS activity and behavioral modulation. -
Triple agonist (GLP-1/GIP/Glucagon) under investigation for weight management and metabolic optimization. Animal studies show enhanced fat oxidation and energy expenditure. -
Essential coenzyme in energy metabolism, redox balance, and DNA repair. Supplementation studied for mitochondrial efficiency and SIRT1–7 pathway activation.
Complimentary Upgrade to 2-Day Shipping on Orders Over $300 | Pay for standard — we’ll handle the upgrade.
You must be logged in to post a comment.